THL Executive Fund VII, L.P., Director at Syneos Health, Inc. (SYNH), sold 6,782,570 shares at $81.04 ($549.7M) on 2021-05-06, disclosed to the SEC on 2021-05-10.
Open-market sale of $549.7M SYNH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.04 | 12 | $972 | 0.0% |
| 2 | $81.04 | 30 | $2K | 0.0% |
| 3 | $81.04 | 208 | $17K | 0.0% |
| 4 | $81.04 | 544 | $44K | 0.0% |
| 5 | $81.04 | 183,292 | $14.9M | 2.7% |
| 6 | $81.04 | 183,292 |
| $14.9M |
| 2.7% |
| 7 | $81.04 | 3,207,596 | $259.9M | 47.3% |
| 8 | $81.04 | 3,207,596 | $259.9M | 47.3% |
| Total | $81.04 avg | 6,782,570 | $549.7M | 100% |
| Filing → |
| SYNH | SELL | 2020-09-21 | $383.2M | — | Filing → |